Oxiquim S.A. (SNSE:OXIQUIM)
Chile · Delayed Price · Currency is CLP 12,446
0.00 (0.00%)
At close: Jan 29, 2026
Oxiquim Income Statement
Financials in millions CLP. Fiscal year is January - December.
Millions CLP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 245,071 | 235,354 | 214,649 | 264,695 | 191,128 | 158,135 | |
Revenue Growth (YoY) | 7.47% | 9.65% | -18.91% | 38.49% | 20.86% | 4.02% |
Cost of Revenue | 164,908 | 156,020 | 143,688 | 186,748 | 129,836 | 105,048 |
Gross Profit | 80,163 | 79,334 | 70,961 | 77,948 | 61,291 | 53,087 |
Selling, General & Admin | 47,299 | 44,460 | 41,921 | 42,902 | 33,870 | 31,036 |
Other Operating Expenses | 1,016 | 879.29 | 903.63 | 904.64 | 590.69 | 503.71 |
Operating Expenses | 48,316 | 45,339 | 42,825 | 43,807 | 34,461 | 31,539 |
Operating Income | 31,847 | 33,994 | 28,136 | 34,141 | 26,830 | 21,548 |
Interest Expense | -2,605 | -2,375 | -2,755 | -2,440 | -1,611 | -1,300 |
Interest & Investment Income | 4,271 | 4,172 | 4,287 | 3,754 | 2,972 | 1,882 |
Currency Exchange Gain (Loss) | -1,729 | -2,304 | -244.04 | -2,382 | -2,357 | 216.04 |
Other Non Operating Income (Expenses) | 2,073 | 1,765 | 2,351 | 4,329 | 1,419 | 575.97 |
EBT Excluding Unusual Items | 33,857 | 35,252 | 31,776 | 37,403 | 27,253 | 22,921 |
Gain (Loss) on Sale of Assets | -1.64 | -6.89 | -159.2 | -42.97 | -5.98 | -3.08 |
Asset Writedown | 9.56 | -0.44 | - | 12.93 | 5.04 | 7.77 |
Legal Settlements | - | - | - | - | - | -25.52 |
Other Unusual Items | -33.27 | -33.27 | -35.01 | -35.09 | -32.54 | - |
Pretax Income | 33,848 | 35,389 | 31,608 | 37,392 | 27,252 | 22,902 |
Income Tax Expense | 8,808 | 9,071 | 7,712 | 8,139 | 6,525 | 5,683 |
Earnings From Continuing Operations | 25,040 | 26,318 | 23,896 | 29,252 | 20,727 | 17,219 |
Earnings From Discontinued Operations | - | - | - | -192.19 | -25.34 | - |
Net Income to Company | 25,040 | 26,318 | 23,896 | 29,060 | 20,702 | 17,219 |
Net Income | 25,040 | 26,318 | 23,896 | 29,060 | 20,702 | 17,219 |
Net Income to Common | 25,040 | 26,318 | 23,896 | 29,060 | 20,702 | 17,219 |
Net Income Growth | -6.22% | 10.13% | -17.77% | 40.38% | 20.23% | 10.35% |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Change (YoY) | 0.01% | 0.00% | - | -0.00% | 0.08% | 0.01% |
EPS (Basic) | 1006.10 | 1057.50 | 960.20 | 1167.71 | 831.80 | 692.40 |
EPS (Diluted) | 1006.10 | 1057.50 | 960.20 | 1167.71 | 831.80 | 692.40 |
EPS Growth | -6.23% | 10.13% | -17.77% | 40.38% | 20.13% | 10.34% |
Free Cash Flow | 20,105 | 18,535 | 26,409 | 3,446 | 10,523 | 11,656 |
Free Cash Flow Per Share | 807.79 | 744.79 | 1061.18 | 138.48 | 422.83 | 468.70 |
Dividend Per Share | 302.000 | 362.000 | 663.000 | 603.000 | 401.000 | 560.000 |
Dividend Growth | -28.44% | -45.40% | 9.95% | 50.37% | -28.39% | -1.93% |
Gross Margin | 32.71% | 33.71% | 33.06% | 29.45% | 32.07% | 33.57% |
Operating Margin | 13.00% | 14.44% | 13.11% | 12.90% | 14.04% | 13.63% |
Profit Margin | 10.22% | 11.18% | 11.13% | 10.98% | 10.83% | 10.89% |
Free Cash Flow Margin | 8.20% | 7.88% | 12.30% | 1.30% | 5.51% | 7.37% |
EBITDA | 41,429 | 42,776 | 34,346 | 38,532 | 30,479 | 25,834 |
EBITDA Margin | 16.91% | 18.18% | 16.00% | 14.56% | 15.95% | 16.34% |
D&A For EBITDA | 9,581 | 8,781 | 6,210 | 4,391 | 3,648 | 4,286 |
EBIT | 31,847 | 33,994 | 28,136 | 34,141 | 26,830 | 21,548 |
EBIT Margin | 13.00% | 14.44% | 13.11% | 12.90% | 14.04% | 13.63% |
Effective Tax Rate | 26.02% | 25.63% | 24.40% | 21.77% | 23.95% | 24.82% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.